This article is more than 5 years old. Information may no longer be current.

FDA approves two topical ciprofloxacin generics

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

The Food and Drug Administration has approved two first-time generic equivalents for ciprofloxacin ophthalmic solution, the agency announced on its Web site. Both Bausch & Lomb and Novex Pharma were granted approval for an ophthalmic solution version of ciprofloxacin earlier this week.

Bausch & Lomb said in a press release that its prescription eye drops are available immediately in 2.5 mL, 5 mL and 10 mL sizes.

The branded form of topical ophthalmic ciprofloxacin is marketed by Alcon as Ciloxan.